Ad
related to: dexcom stock price forecast
Search results
Results From The WOW.Com Content Network
DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track glucose levels. The company slashed its forecast last year, blaming a ...
Canaccord Genuity analyst William Plovanic maintains DexCom with a Buy and raises the price target from $99 to $103. Price Action: DXCM stock is up 6.22% at $89.32 at last check Friday.
Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year. The diabetes-focused healthcare company disappointed investors with its second-quarter results, leading to a ...
DexCom's forward price-to-earnings (P/E) ratio is near three-year lows as of this writing. DXCM PE Ratio (Forward) Chart. ... The stock has been somewhat volatile as a result. DexCom's recent drop ...
Going into 2024, DexCom's (NASDAQ: DXCM) shares were up a whopping 14 times over the last 10 years. The company's continuous glucose monitoring (CGM) devices enjoyed tremendous demand from ...
Right now, DexCom's stock is valued at a price-to-earnings (P/E) multiple of 42. Assuming that valuation holds up over time, it'd have a market cap of roughly $469 billion in 2034, or 1,605% ...
The stock isn't normally this cheap, and investors should take advantage.
(Reuters) -Dexcom shares closed more than 40% lower on Friday after the glucose monitor maker slashed its annual revenue forecast due to the fallout from a salesforce revamp, prompting some ...